EGFR and neoplasm: The epidermal growth factor receptor (EGFR) is an oncogenic tyrosine kinasethat is involved in tumor initiation and progression, making EGFR inhibitorsand monoclonal antibodies to this receptor essential for anti-tumor therapy.